Full history for every metric is available with a Kvantra account
Miromatrix Medical Inc. (MIRO)
Key financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | - | - | 0 | 0 | 0 | 1 | 1 |
| Operating profit | $m | -30 | -28 | |||||
| Net profit | $m | - | - | -3 | -9 | -15 | -30 | -27 |
| EPS reported | $ | -1.45 | -1.13 | |||||
| Operating cashflow per share | $ | -1.29 | -1.29 | |||||
| Capex per share | $ | 0.05 | 0.05 | |||||
| FCF per share | $ | -1.34 | -1.34 | |||||
| Free cash flow | $m | -28 | -25 | |||||
| Net debt | $m | -22 | -16 | |||||
| Book value equity | $m | 26 | 16 | |||||
| Book value per share | $ | 1.26 | 0.57 | |||||
| Number of shares | m | 20.73 | 27.31 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 2.37 | 5.98 | |||||
| P/S LTM | x | 65.00 | 97.02 | |||||
| P/FCF LTM | x | -2.23 | -3.79 | |||||
| EV/EBITDA LTM | x | -2.03 | -2.95 | |||||
| EV/Sales LTM | x | 63.26 | 80.66 | |||||
| Earnings Yield LTM | % | -48.42% | -42.70% | |||||
| FCF Yield | % | -44.77% | -26.41% | |||||
| Quality | ||||||||
| ROE | % | -114.94% | -74.80% | |||||
| ROIC | % | -99.98% | -99.98% | |||||
| Operating margin | % | -3172.2% | -3172.2% | |||||
| Gross margin | % | 47.56% | 47.56% | |||||
| FCF/Sales | % | -2910.0% | -2910.0% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | +2783.5% | +2979.0% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | -1.59% | |||||
| FCF/Debt | x | -7.81 | -7.62 | |||||
| Net Debt/EBITDA | x | 0.06 | 0.06 | |||||
| EBIT/Net interest | x | -633.66 | -633.66 | |||||
| Net debt/market cap | % | -34.92% | -16.86% | |||||
| Net debt/Equity | x | -0.83 | -1.01 | |||||
| Gross debt/equity | x | 0.14 | 0.21 | |||||
Company overview
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Miromatrix Medical Inc. (MIRO)
Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free